Obesity has grown to be a full-scale epidemic, and GLP-1s are hailed by some as the miracle cure. What’s your organization’s strategy for addressing increasing consumer demand for weight loss drugs? Will you or won’t you cover the cost of these drugs for your employees and plan members? For answers to these critical questions — and more — we recommend our comprehensive Employer Impact Report on Weight Loss Drugs.